Capital International Sarl Grows Stock Holdings in Mettler-Toledo International, Inc. $MTD

Capital International Sarl increased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 32.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,766 shares of the medical instruments supplier’s stock after buying an additional 4,570 shares during the quarter. Capital International Sarl owned about 0.09% of Mettler-Toledo International worth $26,163,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MTD. Norges Bank purchased a new position in shares of Mettler-Toledo International during the fourth quarter worth about $520,989,000. M&T Bank Corp grew its holdings in shares of Mettler-Toledo International by 2,813.6% during the fourth quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after buying an additional 119,942 shares during the last quarter. Capital International Investors boosted its holdings in Mettler-Toledo International by 12.7% in the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after purchasing an additional 109,508 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Mettler-Toledo International by 10.7% in the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in Mettler-Toledo International by 39,107.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 61,556 shares of the medical instruments supplier’s stock valued at $85,821,000 after purchasing an additional 61,399 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lowered their price objective on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Morgan Stanley lowered their price objective on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Finally, Citigroup lowered their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $1,408.55.

View Our Latest Stock Report on MTD

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,153.99 on Friday. The business’s 50 day simple moving average is $1,215.48 and its 200-day simple moving average is $1,323.08. The firm has a market capitalization of $23.32 billion, a price-to-earnings ratio of 27.06, a price-to-earnings-growth ratio of 2.41 and a beta of 1.27. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

See Also

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.